In a significant turn of events in COVID-19 testing, the U.S. Food and Drug Administration granted an emergency authorization for the public to begin employing a saliva-based test expected to significantly increase the availability, turnaround time and affordability of combating the coronavirus epidemic in the United States.
Developed by Yale University and jointly funded by the NBA and NBA Players Association, the testing method was granted approval by the FDA on Saturday.
The test — coined SalivaDirect — was developed to throttle up the screening process for a wide swath of Americans. The FDA approval marks a significant turn for testing in the U.